Brent A. Neuschwander‐Tetri

Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions

Elizabeth M. Brunt, Christine G. Janney, Adrian M. Di Bisceglie et al. · The American Journal of Gastroenterology · 1999 · 3.9K citations

Medicine, Internal Medicine, Pathology +17

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

Arun J. Sanyal, Naga Chalasani, Kris V. Kowdley et al. · New England Journal of Medicine · 2010 · 3.3K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +7

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui et al. · Hepatology · 2023 · 2.3K citations · Full text

Medicine, Pediatrics, Hepatology +13

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal et al. · The Lancet · 2014 · 2.2K citations

Medicine, Internal Medicine, Pharmacology +14

Nonalcoholic Fatty Liver Disease (NAFLD) Activity Score and the Histopathologic Diagnosis in NAFLD: Distinct Clinicopathologic Meanings §Δ

Elizabeth M. Brunt, David E. Kleiner, Laura Wilson et al. · Hepatology · 2010 · 1.2K citations · Full text

Medicine, Pathology, Gastroenterology +16